Literature DB >> 20189673

Predictors of diastolic dysfunction among minority patients with newly diagnosed type 2 diabetes.

Rasa Kazlauskaite1, Rami Doukky, Arthur Evans, Bosko Margeta, Arora Ruchi, Leon Fogelfeld, Russell F Kelly.   

Abstract

AIM: To determine mutable risk factors for asymptomatic diastolic dysfunction in ethnic minority patients newly diagnosed with type 2 diabetes.
METHODS: We recruited consecutive adults with newly diagnosed diabetes who had no signs or symptoms or history of heart disease. All patients received standardized evaluation including interview, physical examination, laboratory tests and echocardiogram with tissue Doppler studies. We used logistic regression models to identify mutable risk factors for diastolic dysfunction.
RESULTS: Among 126 study subjects (52% women, age 45+/-10 years, BMI 33+/-7, 42% with hypertension, 100% ejection fraction > or =50%), evidence of diastolic dysfunction was present in 64 (51%). After controlling for age, heart rate and blood pressure, independent predictors of diastolic dysfunction included physical inactivity (OR: 2.3; 95% CI: 0.9-6.1; P=0.08) and glucose (OR: 4.9; 95% CI: 1.4-17.8; P=0.02). Physical inactivity was associated with early diastolic dysfunction (impaired relaxation), whereas epicardial fat thickness and glucose levels were associated with late diastolic dysfunction (impaired compliance). The hs-CRP and BNP levels were not associated with diastolic dysfunction.
CONCLUSIONS: Asymptomatic diastolic dysfunction was prevalent among urban minority patients newly diagnosed with diabetes. Important differences exist among factors that affect early and late diastolic function that may have prognostic and therapeutic implications. Copyright 2010. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20189673      PMCID: PMC3390420          DOI: 10.1016/j.diabres.2009.12.007

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  25 in total

Review 1.  Follow-up report on the diagnosis of diabetes mellitus.

Authors:  Saul Genuth; K G M M Alberti; Peter Bennett; John Buse; Ralph Defronzo; Richard Kahn; John Kitzmiller; William C Knowler; Harold Lebovitz; Ake Lernmark; David Nathan; Jerry Palmer; Robert Rizza; Christopher Saudek; Jonathan Shaw; Michael Steffes; Michael Stern; Jaako Tuomilehto; Paul Zimmet
Journal:  Diabetes Care       Date:  2003-11       Impact factor: 19.112

2.  Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study).

Authors:  M Galderisi; K M Anderson; P W Wilson; D Levy
Journal:  Am J Cardiol       Date:  1991-07-01       Impact factor: 2.778

3.  Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale.

Authors:  L Goldman; B Hashimoto; E F Cook; A Loscalzo
Journal:  Circulation       Date:  1981-12       Impact factor: 29.690

4.  The incidence of congestive heart failure in type 2 diabetes: an update.

Authors:  Gregory A Nichols; Christina M Gullion; Carol E Koro; Sara A Ephross; Jonathan B Brown
Journal:  Diabetes Care       Date:  2004-08       Impact factor: 19.112

Review 5.  Heart failure: the frequent, forgotten, and often fatal complication of diabetes.

Authors:  David S H Bell
Journal:  Diabetes Care       Date:  2003-08       Impact factor: 19.112

6.  Screening for alcohol abuse using the CAGE questionnaire.

Authors:  B Bush; S Shaw; P Cleary; T L Delbanco; M D Aronson
Journal:  Am J Med       Date:  1987-02       Impact factor: 4.965

7.  Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic.

Authors:  Margaret M Redfield; Steven J Jacobsen; John C Burnett; Douglas W Mahoney; Kent R Bailey; Richard J Rodeheffer
Journal:  JAMA       Date:  2003-01-08       Impact factor: 56.272

8.  Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study.

Authors:  Margaret M Redfield; Richard J Rodeheffer; Steven J Jacobsen; Douglas W Mahoney; Kent R Bailey; John C Burnett
Journal:  Circulation       Date:  2004-06-07       Impact factor: 29.690

9.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.

Authors:  K G M M Alberti; Robert H Eckel; Scott M Grundy; Paul Z Zimmet; James I Cleeman; Karen A Donato; Jean-Charles Fruchart; W Philip T James; Catherine M Loria; Sidney C Smith
Journal:  Circulation       Date:  2009-10-05       Impact factor: 29.690

10.  Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings.

Authors:  P N Casale; R B Devereux; D R Alonso; E Campo; P Kligfield
Journal:  Circulation       Date:  1987-03       Impact factor: 29.690

View more
  5 in total

Review 1.  Cardiac adipose tissue and its relationship to diabetes mellitus and cardiovascular disease.

Authors:  Adam M Noyes; Kirandeep Dua; Ramprakash Devadoss; Lovely Chhabra
Journal:  World J Diabetes       Date:  2014-12-15

Review 2.  Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes.

Authors:  Teresa Salvatore; Raffaele Galiero; Alfredo Caturano; Erica Vetrano; Luca Rinaldi; Francesca Coviello; Anna Di Martino; Gaetana Albanese; Sara Colantuoni; Giulia Medicamento; Raffaele Marfella; Celestino Sardu; Ferdinando Carlo Sasso
Journal:  Biomolecules       Date:  2022-01-21

3.  High Sensitivity C - Reactive Protein is Associated with Diastolic Dysfunction in Young African Americans without Clinically Evident Cardiac Disease.

Authors:  Venkataraman Rajaram; Arthur T Evans; Gloria C Caldito; Russell F Kelly; Leon Fogelfeld; Henry R Black; Rami Doukky
Journal:  Open Cardiovasc Med J       Date:  2011-08-22

Review 4.  Characterization of the inflammatory-metabolic phenotype of heart failure with a preserved ejection fraction: a hypothesis to explain influence of sex on the evolution and potential treatment of the disease.

Authors:  Milton Packer; Carolyn S P Lam; Lars H Lund; Mathew S Maurer; Barry A Borlaug
Journal:  Eur J Heart Fail       Date:  2020-06-26       Impact factor: 15.534

5.  The prevalence of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction in men and women with type 2 diabetes: A systematic review and meta-analysis.

Authors:  Selma Bouthoorn; Gideon B Valstar; Aisha Gohar; Hester M den Ruijter; Hans B Reitsma; Arno W Hoes; Frans H Rutten
Journal:  Diab Vasc Dis Res       Date:  2018-07-24       Impact factor: 3.291

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.